These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10968287)

  • 41. Binding of phosphorothioate oligodeoxynucleotides to basic fibroblast growth factor, recombinant soluble CD4, laminin and fibronectin is P-chirality independent.
    Benimetskaya L; Tonkinson JL; Koziolkiewicz M; Karwowski B; Guga P; Zeltser R; Stec W; Stein CA
    Nucleic Acids Res; 1995 Nov; 23(21):4239-45. PubMed ID: 7501441
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Photomodulation of PS-modified oligonucleotides containing azobenzene substituent at pre-selected positions in phosphate backbone.
    Patnaik S; Kumar P; Garg BS; Gandhi RP; Gupta KC
    Bioorg Med Chem; 2007 Dec; 15(24):7840-9. PubMed ID: 17870546
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ribonuclease P (RNase P) RNA is converted to a Cd(2+)-ribozyme by a single Rp-phosphorothioate modification in the precursor tRNA at the RNase P cleavage site.
    Warnecke JM; Fürste JP; Hardt WD; Erdmann VA; Hartmann RK
    Proc Natl Acad Sci U S A; 1996 Aug; 93(17):8924-8. PubMed ID: 8799129
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of human immunodeficiency virus type 1 replication by P-stereodefined oligo(nucleoside phosphorothioate)s in a long-term infection model.
    Inagawa T; Nakashima H; Karwowski B; Guga P; Stec WJ; Takeuchi H; Takaku H
    FEBS Lett; 2002 Sep; 528(1-3):48-52. PubMed ID: 12297278
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Toxicologic effects of an oligodeoxynucleotide phosphorothioate and its analogs following intravenous administration in rats.
    Agrawal S; Zhao Q; Jiang Z; Oliver C; Giles H; Heath J; Serota D
    Antisense Nucleic Acid Drug Dev; 1997 Dec; 7(6):575-84. PubMed ID: 9450915
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The influence of oligodeoxyribonucleotide phosphorothioate pyrimidine strands on triplex stability.
    Tsukahara S; Kim SG; Takaku H
    Nucleic Acids Symp Ser; 1992; (27):121-2. PubMed ID: 1289787
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Spectroscopic evidence for the formation of four-stranded solution structure of oligodeoxycytidine phosphorothioate.
    Kanehara H; Mizuguchi M; Tajima K; Kanaori K; Makino K
    Biochemistry; 1997 Feb; 36(7):1790-7. PubMed ID: 9048563
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis of phosphorothioate analogues of oligodeoxyribonucleotides and their antiviral activity against human immunodeficiency virus (HIV).
    Matsukura M; Zon G; Shinozuka K; Stein CA; Mitsuya H; Cohen JS; Broder S
    Gene; 1988 Dec; 72(1-2):343-7. PubMed ID: 3243433
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of phosphorothioate capping on antisense oligonucleotide stability, hybridization and antiviral efficacy versus herpes simplex virus infection.
    Hoke GD; Draper K; Freier SM; Gonzalez C; Driver VB; Zounes MC; Ecker DJ
    Nucleic Acids Res; 1991 Oct; 19(20):5743-8. PubMed ID: 1658742
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antisense oligonucleotides as therapeutic agents--is the bullet really magical?
    Stein CA; Cheng YC
    Science; 1993 Aug; 261(5124):1004-12. PubMed ID: 8351515
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chirality matters: stereo-defined phosphorothioate linkages at the termini of small interfering RNAs improve pharmacology in vivo.
    Jahns H; Taneja N; Willoughby JLS; Akabane-Nakata M; Brown CR; Nguyen T; Bisbe A; Matsuda S; Hettinger M; Manoharan RM; Rajeev KG; Maier MA; Zlatev I; Charisse K; Egli M; Manoharan M
    Nucleic Acids Res; 2022 Feb; 50(3):1221-1240. PubMed ID: 34268578
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The influence of oligodeoxyribonucleotide phosphorothioate pyrimidine strands on triplex formation.
    Kim SG; Tsukahara S; Yokoyama S; Takaku H
    FEBS Lett; 1992 Dec; 314(1):29-32. PubMed ID: 1451802
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Random sequence phosphorothioate oligonucleotides evoke dramatic phenotypic alterations in cardiac myocyte cultures.
    Davis DL; Doten IC; Barald KF; Axelrod D; Burch JB
    Antisense Nucleic Acid Drug Dev; 1996; 6(4):259-65. PubMed ID: 9012861
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sequence-specific antitumor activity of a phosphorothioate oligodeoxyribonucleotide targeted to human C-raf kinase supports an antisense mechanism of action in vivo.
    Monia BP; Sasmor H; Johnston JF; Freier SM; Lesnik EA; Muller M; Geiger T; Altmann KH; Moser H; Fabbro D
    Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15481-4. PubMed ID: 8986837
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of partially phosphorothioated "antisense" oligodeoxynucleotides for sequence-dependent modulation of hematopoiesis in culture.
    Ehrlich G; Patinkin D; Ginzberg D; Zakut H; Eckstein F; Soreq H
    Antisense Res Dev; 1994; 4(3):173-83. PubMed ID: 7849488
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Duplex stabilities of phosphorothioate, methylphosphonate, and RNA analogs of two DNA 14-mers.
    Kibler-Herzog L; Zon G; Uznanski B; Whittier G; Wilson WD
    Nucleic Acids Res; 1991 Jun; 19(11):2979-86. PubMed ID: 1711677
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 2'-O-methyl-modified phosphorothioate antisense oligonucleotides have reduced non-specific effects in vitro.
    Yoo BH; Bochkareva E; Bochkarev A; Mou TC; Gray DM
    Nucleic Acids Res; 2004; 32(6):2008-16. PubMed ID: 15064360
    [TBL] [Abstract][Full Text] [Related]  

  • 58. p53 interference and growth inhibition in p53-mutant and overexpressing endometrial cancer cell lines.
    Janicek MF; Angioli R; Unal AD; Sevin BU; Madrigal M; Estape R; Averette HE
    Gynecol Oncol; 1997 Jul; 66(1):94-102. PubMed ID: 9234928
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of phosphorothioate and 2-amino groups in hammerhead ribozymes on cleavage rates and Mg2+ binding.
    Koizumi M; Ohtsuka E
    Biochemistry; 1991 May; 30(21):5145-50. PubMed ID: 2036380
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structural and immunostimulatory properties of Y-shaped DNA consisting of phosphodiester and phosphorothioate oligodeoxynucleotides.
    Matsuoka N; Nishikawa M; Mohri K; Rattanakiat S; Takakura Y
    J Control Release; 2010 Dec; 148(3):311-6. PubMed ID: 20887761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.